(Q40006010)

16 September 2017

title

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells (English)

1 reference

16 September 2017

main subject

hepatocellular carcinoma

1 reference

4

1 reference

16 September 2017

Emilia Fransvea

1

1 reference

16 September 2017

Umberto Angelotti

series ordinal

2

1 reference

16 September 2017

Salvatore Antonaci

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

47

1 reference

16 September 2017

issue

5

1 reference

16 September 2017

page(s)

1557-1566

1 reference

Hepatocellular carcinoma: recent trends in the United States

16 September 2017

cites work

1 reference

7 January 2021

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

1 reference

7 January 2021

Novel concepts in hepatocellular carcinoma: from molecular research to clinical practice.

1 reference

7 January 2021

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin

1 reference

7 January 2021

Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma

1 reference

7 January 2021

Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma

1 reference

7 January 2021

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

1 reference

7 January 2021

Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma

1 reference

7 January 2021

Epithelial-mesenchymal transitions in tumour progression

1 reference

7 January 2021

Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

1 reference

7 January 2021

The specificities of protein kinase inhibitors: an update

1 reference

7 January 2021

Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.

1 reference

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

7 January 2021

Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma

1 reference

7 January 2021

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

1 reference

7 January 2021

Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids

1 reference

7 January 2021

Biology of transforming growth factor beta in hepatocarcinogenesis

1 reference

7 January 2021

Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes

1 reference

7 January 2021

Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition.

1 reference

7 January 2021

Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment.

1 reference

7 January 2021

Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22201

1 reference

16 September 2017

1 reference